http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020009266-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_58c8cf5e272691db3c376434b0aa7f99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e0daec85fdd4a4c04e22225e70a5cd9
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-17043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2227-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0387
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1217
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y207-02003
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-193
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-535
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
filingDate 2018-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39c42eebdcc41c35f1ecb60f0ec661ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b7f506fe2b818a500020d9bac030ab7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4b0113efa0360a8d79a3c5fdd6f1ba4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95703b2bfe581daccde9c5415a787ba6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a167b11e50160343205b4eeff846f3e1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_375f87a0685cbb5dec30cf440b1abb14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c04254fa2a134cfb71d69bce085c0dc
publicationDate 2020-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2020009266-A1
titleOfInvention In vivo gene therapy for immune deficiencies
abstract In vivo gene therapies for immune deficiencies are described. The in vivo gene therapies utilize a foamy viral vector including a PGK promoter with a therapeutic gene. The foamy viral vector can be beneficially administered with cell mobilization into the peripheral blood.
priorityDate 2017-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425718605
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID153156307

Total number of triples: 34.